As the largest pure-play API/CDMO, Divi's should continue benefiting from custom-synthesis order-book conversion and the ...
Axis Direct said that SBI Cards confirmed a short-term trend reversal on the daily charts by forming a double bottom ...
At close, shares of Divi's Laboratories traded 1.65 per cent or Rs 59.65 higher, at Rs 3,681 apiece on the BSE. The market ...
Stay up-to-date with the Divis Labs Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...
For the December quarter of the FY25, pharma major Divi's Laboratories reported a 64 per cent year-on-year (YoY) jump in ...
NDTV Profit on MSN
Citi picks Divi's as top India pharma bet, sees peptide pipeline driving next leg of growth
The brokerage expects supplies for GLP-1 molecules to begin in FY27, while two key oral peptide opportunities, Enlicitide and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results